Gala Renee D
GALA RENEE D, PRES, CEO, reported a transaction classified as withholding at Jazz Pharmaceuticals plc involving 1967.000000 shares for an estimated $485475.27. Reported holdings after the transaction were 145394.000000 shares. The stored filing text includes a detected 10b5-1 reference.
- Trade date
- Sep 08, 2026
- Filing date
- Sep 10, 2026
How reported position traded is calculated
Calculated only for code-P purchases and code-S sales.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
JAZZ price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- withholding Code F
- Identifier
- 0001607737-26-000013 Ordinary Shares
- Transaction date
- Sep 08, 2026 Filed Sep 10, 2026, 08:33 PM · 2d delay
- Shares
- 1,967 sh $246.81 per share
- Estimated value
- -$485k Computed from shares × price
- Holdings after
- 145,394 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
-22 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a meaningfully negative filing-only score. It is likely less useful as a positive insider-activity signal.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 2
Filing reported within two business days of the transaction. - tax_withholding-22 points
transaction_code = F
Tax withholding on vesting shares is mechanical. - tenb5_1_detected-10 points
is_10b5_1 = true
Stored filing content includes detected 10b5-1 language.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
President & CEO
- F1
Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.
- F2
This transaction was made pursuant to a plan adopted by the reporting person on June 4, 2026 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred…
0 other transactions
0 recent txs